Man Group’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-140,000
Closed -$2.92M 2355
2022
Q3
$2.92M Buy
+140,000
New +$2.91M 0.01% 933
2022
Q2
Sell
-177,441
Closed -$3.16M 992
2022
Q1
$2.98M Buy
177,441
+4,826
+3% +$84.4K 0.01% 1091
2021
Q4
$3.45M Sell
172,615
-64
-0% -$1.21K 0.01% 1010
2021
Q3
$3.13M Buy
172,679
+6,089
+4% +$140K 0.01% 1025
2021
Q2
$4.5M Buy
166,590
+74,962
+82% +$2.1M 0.02% 928
2021
Q1
$2.75M Buy
91,628
+74,356
+431% +$2.54M 0.01% 986
2020
Q4
$496K Buy
+17,272
New +$466K ﹤0.01% 1555
2020
Q1
Sell
-35,235
Closed -$465K 1973
2019
Q4
$465K Sell
35,235
-127,775
-78% -$1.55M ﹤0.01% 1603
2019
Q3
$1.94M Sell
163,010
-66,764
-29% -$1.24M 0.01% 1251
2019
Q2
$5.62M Buy
+229,774
New +$6.62M 0.02% 901

Other funds holding CVET

Man Group's CVET Position: Q4 2022 in Review

Man Group sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 140,000 shares — an estimated $2.92M sold.

Man Group first reported a position in CVET in Q2 2019 and held it in 10 quarters. The position peaked at $5.62M in Q2 2019. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Man Group reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Man Group sold 140,000 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $2.92M.
  • Man Group first reported a position in Covetrus, Inc. Common Stock in Q2 2019 and held it in 10 quarters.
  • Man Group's Covetrus, Inc. Common Stock position peaked at $5.62M in Q2 2019.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Man Group's 13F filing for Q4 2022, filed 14 Feb 2023.